Hemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles

Nanoscale Research Letters

Volumn 7, Issue , 2012, Pages 1-9

  Higashisaka, Kazuma ^a   Yoshioka, Yasuo ^a   Yamashita, Kohei ^a   Morishita, Yuki ^a   Pan, Huiyan ^a   Ogura, Toshinobu ^a   Nagano, Takashi ^a   Kunieda, Akiyoshi ^a   Nagano, Kazuya ^b   Abe, Yasuhiro ^c   Kamada, Haruhiko ^a,b   Tsunoda, Shin ichi ^a,b   Nabeshi, Hiromi ^d   Yoshikawa, Tomoaki ^a   Tsutsumi, Yasuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c SANFORD RESEARCH   (United States)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Biomarker; Hemolysis; Plasma proteins; Silica nanoparticle

Indexed keywords

ELECTROPHORESIS; MAMMALS; MASS SPECTROMETRY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; PROTEINS; RISK ASSESSMENT; SAFETY ENGINEERING; SILICA; SILICA NANOPARTICLES;

ASSESSMENT SYSTEM; BIOLOGICAL RESPONSE; GEL ELECTROPHORESIS; HEMOLYSIS; INTRAVENOUS INJECTIONS; PLASMA PROTEIN; QUANTITATIVE IMAGE ANALYSIS; SILICA PARTICLE SIZE;

BIOMARKERS;

EID: 84870994484     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-7-555     Document Type: Article

References (40)

1. Augustin MA, Sanguansri P: Nanostructured materials in the food industry. Adv Food Nutr Res 2009, 58:183-213.
2. Bowman DM, van Calster G, Friedrichs S: Nanomaterials and regulation of cosmetics. Nat Nanotechnol 2010, 5:92.
3. Kagan VE, Bayir H, Shvedova AA: Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 2005, 1:313-316.
4. Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
5. Merget R, Bauer T, Kupper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T: Health hazards due to the inhalation of amorphous silica. Arch Toxicol 2002, 75:625-634.
6. Knopp D, Tang D, Niessner R: Review: bioanalytical applications of biomolecule-functionalized nanometer-sized doped silica particles. Anal Chim Acta 2009, 647:14-30.
7. Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH: The nanosilica hazard: another variable entity. Part Fibre Toxicol 2010, 7:39.
8. Lankoff A, Arabski M, Wegierek-Ciuk A, Kruszewski M, Lisowska H, Banasik-Nowak A, Rozga-Wijas K, Wojewodzka M, Slomkowski S: Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology 2012. doi:10.3109/17435390.2011.649796.
9. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Nakagawa S, Mayumi T, Tsunoda S, Tsutsumi Y: Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials 2011, 32:2713-2724.
10. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Tochigi S, Kondoh S, Hirai T, Akase T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Itoh N, Tsunoda S, Tsutsumi Y: Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part Fibre Toxicol 2011, 8:1.
11. Nabeshi H, Yoshikawa T, Arimori A, Yoshida T, Tochigi S, Hirai T, Akase T, Nagano K, Abe Y, Kamada H, Tsunoda S, Itoh N, Yoshioka Y, Tsutsumi Y: Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett 2011, 6:93.
12. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Kondoh M, Yagi K, Mayumi T, Tsunoda S, Tsutsumi Y: Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology 2012, 23:045101.
13. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, Yoshida T, Ogura T, Nabeshi H, Nagano K, Abe Y, Kamada H, Monobe Y, Imazawa T, Aoshima H, Shishido K, Kawai Y, Mayumi T, Tsunoda S, Itoh N, Yoshikawa T, Yanagihara I, Saito S, Tsutsumi Y: Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011, 6:321-328.
14. Casado B, Iadarola P, Luisetti M, Kussmann M: Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev Proteomics 2008, 5:693-704.
15. Ferte C, Andre F, Soria JC: Molecular circuits of solid tumors: prognostic and predictive tools for bedside use. Nat Rev Clin Oncol 2010, 7:367-380.
16. Li N, Nel AE: Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research. J Occup Environ Med 2011, 53:S74-79.
17. Higashisaka K, Yoshioka Y, Yamashita K, Morishita Y, Fujimura M, Nabeshi H, Nagano K, Abe Y, Kamada H, Tsunoda S, Yoshikawa T, Itoh N, Tsutsumi Y: Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomaterials 2011, 32:3-9.
18. He X, Nie H, Wang K, Tan W, Wu X, Zhang P: In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem 2008, 80:9597-9603.
19. Tolosano E, Altruda F: Hemopexin: structure, function, and regulation. DNA Cell Biol 2002, 21:297-306.
20. Delanghe JR, Langlois MR: Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001, 312:13-23.
21. Vinchi F, Gastaldi S, Silengo L, Altruda F, Tolosano E: Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 2008, 173:289-299.
22. Lagan AL, Melley DD, Evans TW, Quinlan GJ: Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. Am J Physiol Lung Cell Mol Physiol 2008, 294:L161-174.
23. Nielsen MJ, Moestrup SK: Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 2009, 114:764-771.
24. Nielsen MJ, Moller HJ, Moestrup SK: Hemoglobin and heme scavenger receptors. Antioxid Redox Signal 2010, 12:261-273.
25. Lopez JL: Two-dimensional electrophoresis in proteome expression analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 849:190-202.
26. Sa-Correia I, Teixeira MC: 2D electrophoresis-based expression proteomics: a microbiologist's perspective. Expert Rev Proteomics 2010, 7:943-953.
27. Aggarwal K, Choe LH, Lee KH: Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic 2006, 5:112-120.
28. Treumann A, Thiede B: Isobaric protein and peptide quantification: perspectives and issues. Expert Rev Proteomics 2010, 7:647-653.
29. Xu J, Khor KA, Sui J, Zhang J, Tan TL, Chen WN: Comparative proteomics profile of osteoblasts cultured on dissimilar hydroxyapatite biomaterials: an iTRAQ-coupled 2-D LC-MS/MS analysis. Proteomics 2008, 8:4249-4258.
30. Yang X, Yang S, Wang J, Zhang X, Wang C, Hong G: Expressive proteomics profile changes of injured human brain cortex due to acute brain trauma. Brain Inj 2009, 23:830-840.
31. Gerashchenko BI, Gun'ko VM, Gerashchenko II, Mironyuk IF, Leboda R, Hosoya H: Probing the silica surfaces by red blood cells. Cytometry 2002, 49:56-61.
32. Murashov V, Harper M, Demchuk E: Impact of silanol surface density on the toxicity of silica aerosols measured by erythrocyte haemolysis. J Occup Environ Hyg 2006, 3:718-723.
33. Slowing II, Wu CW, Vivero-Escoto JL, Lin VS: Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
34. Lin YS, Haynes CL: Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.
35. Yu T, Malugin A, Ghandehari H: Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
36. Manuel Y, Defontaine MC, Bourgoin JJ, Dargent M, Sonneck JM: Serum haemopexin levels in patients with malignant melanoma. Clin Chim Acta 1971, 31:485-486.
37. Coombes RC, Powles TJ, Neville AM: Evaluation of biochemical markers in breast cancer. Proc R Soc Med 1977, 70:843-845.
38. Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharpe S: Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997, 66:1-11.
39. Immenschuh S, Song DX, Satoh H, Muller-Eberhard U: The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun 1995, 207:202-208.
40. Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, Lambert AJ, Schelling SH, Medley QG, Ma HL, Collins M, Dunussi-Joannopoulos K, Fouser LA: IL-22 induces an acute-phase response. J Immunol 2010, 185:5531-5538.